Connect Biopharma is a publicly traded company trading on NASDAQ, led by CEO Barry D. Quart.
Upcoming earnings announcement for Connect Biopharma
Past 10 earnings reports for Connect Biopharma
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Q3 2025 | -$0.31Est: -$0.27 | -14.8% | $16.0K | — | |
| Aug 13, 2025 | Q2 2025 | -$0.23Est: -$0.22 | -4.5% | $48.0K | — | |
| May 15, 2025 | Q1 2025 | -$0.19 | — | - | — | |
| Mar 31, 2025 | FY 2024 | -$0.28 | — | $26.0M | — | |
| Sep 5, 2024 | H1 2024 | $0.14 | — | $24.1M | — | — |
| Apr 16, 2024 | FY 2023 | -$1.08 | — | - | — | — |
| Sep 12, 2023 | H1 2023 | -$0.50 | — | - | — | — |
| Apr 11, 2023 | FY 2022 | -$2.10 | — | - | — | — |
| Sep 13, 2022 | H1 2022 | -$1.10 | — | - | — | — |
| Mar 31, 2022 | FY 2021 | -$3.90 | — | - | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.